Canagliflozin hemihydrate

Overview

Canagliflozin hemihydrate is a highly potent and selective inhibitor of subtype 2 sodium-glucose transport protein (SGLT2), which is responsible for at least 90% of the glucose reabsorption in the kidney. It is an experimental drug being developed by Johnson & Johnson for the treatment of type 2 diabetes.

Application

Products > Life Science > Carbohydrates, Nucleosides & Nucleotides > Carbohydrates > Glycosides | Products > Drug Discovery > Inhibitor

Product Information

• Catalog No.: B0084-463685
• CAS No.: 928672-86-0
• Molecular Formula: C24H25FO5S.1/2H2O
• Molecular Weight: 453.53
• Purity: >98%

Source

Original product source